Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.

Tsai WL, Lai KH, Liang HL, Hsu PI, Chan HH, Chen WC, Yu HC, Tsay FW, Wang HM, Tsai HC, Cheng JS.

PLoS One. 2014 May 13;9(5):e92784. doi: 10.1371/journal.pone.0092784. eCollection 2014.

PMID:
24824520
[PubMed - in process]
Free PMC Article
2.

A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinoma.

Kim HY, Kim JD, Bae SH, Park JY, Han KH, Woo HY, Choi JY, Yoon SK, Jang BK, Hwang JS, Kim SG, Kim YS, Seo YS, Yim HJ, Um SH; Korean Liver Cancer Study Group.

Korean J Hepatol. 2010 Dec;16(4):355-61. doi: 10.3350/kjhep.2010.16.4.355.

PMID:
21415578
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Is hepatic arterial infusion chemotherapy effective treatment for advanced hepatocellular carcinoma resistant to transarterial chemoembolization?

Kirikoshi H, Yoneda M, Mawatari H, Fujita K, Imajo K, Kato S, Suzuki K, Kobayashi N, Kubota K, Maeda S, Nakajima A, Saito S.

World J Gastroenterol. 2012 Apr 28;18(16):1933-9. doi: 10.3748/wjg.v18.i16.1933.

PMID:
22563174
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative study.

Hiramine Y, Uto H, Imamura Y, Tabu K, Baba Y, Hiwaki T, Sho Y, Tahara K, Higashi H, Tamai T, Oketani M, Ido A, Tsubouchi H.

Exp Ther Med. 2011 May;2(3):433-441. Epub 2011 Mar 21.

PMID:
22977522
[PubMed]
Free PMC Article
5.

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in Japan.

Nishikawa H, Osaki Y, Kita R, Kimura T.

Cancers (Basel). 2012 Feb 21;4(1):165-83. doi: 10.3390/cancers4010165.

PMID:
24213234
[PubMed]
Free PMC Article
6.

Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.

Asahara T, Itamoto T, Katayama K, Ono E, Dohi K, Nakanishi T, Kitamoto M, Azuma K, Ito K.

Hepatogastroenterology. 1999 Mar-Apr;46(26):1042-8.

PMID:
10370664
[PubMed - indexed for MEDLINE]
7.

Transarterial chemoembolization as salvage therapy after unsuccessful hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma.

Fukumori K, Yano Y, Ando E, Sumie S, Kuwaki K, Yamashita F, Tanaka M, Sata M.

Mol Med Rep. 2008 Jul-Aug;1(4):521-4.

PMID:
21479443
[PubMed]
8.

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases.

Ando E, Tanaka M, Yamashita F, Kuromatsu R, Yutani S, Fukumori K, Sumie S, Yano Y, Okuda K, Sata M.

Cancer. 2002 Aug 1;95(3):588-95.

PMID:
12209752
[PubMed - indexed for MEDLINE]
Free Article
9.

A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Song DS, Song MJ, Bae SH, Chung WJ, Jang JY, Kim YS, Lee SH, Park JY, Yim HJ, Cho SB, Park SY, Yang JM.

J Gastroenterol. 2014 Jul 16. [Epub ahead of print]

PMID:
25027973
[PubMed - as supplied by publisher]
10.

The role of 3D-conformal radiotherapy for major portal vein tumor thrombosis combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.

Fujino H, Kimura T, Aikata H, Miyaki D, Kawaoka T, Kan H, Fukuhara T, Kobayashi T, Naeshiro N, Honda Y, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Takahashi S, Yoshimatsu R, Yamagami T, Kenjo M, Nagata Y, Awai K, Chayama K.

Hepatol Res. 2014 Jul 23. doi: 10.1111/hepr.12392. [Epub ahead of print]

PMID:
25052365
[PubMed - as supplied by publisher]
11.

Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.

Sumie S, Yamashita F, Ando E, Tanaka M, Yano Y, Fukumori K, Sata M.

AJR Am J Roentgenol. 2003 Nov;181(5):1327-34.

PMID:
14573429
[PubMed - indexed for MEDLINE]
12.

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy.

Oh MJ, Lee HJ, Lee SH.

Clin Mol Hepatol. 2013 Sep;19(3):288-99. doi: 10.3350/cmh.2013.19.3.288. Epub 2013 Sep 30.

PMID:
24133667
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].

Fan J, Wu Z, Tang Z.

Zhonghua Wai Ke Za Zhi. 2001 Oct;39(10):745-8. Chinese.

PMID:
16201184
[PubMed - indexed for MEDLINE]
14.

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma by placing a temporary catheter via the subclavian route.

Liang HL, Huang JS, Lin YH, Lai KH, Yang CF, Pan HB.

Acta Radiol. 2007 Sep;48(7):734-40.

PMID:
17729003
[PubMed - indexed for MEDLINE]
15.

Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma.

Park JY, Ahn SH, Yoon YJ, Kim JK, Lee HW, Lee do Y, Chon CY, Moon YM, Han KH.

Cancer. 2007 Jul 1;110(1):129-37.

PMID:
17508408
[PubMed - indexed for MEDLINE]
Free Article
16.

The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study.

Yu Y, Lang Q, Chen Z, Li B, Yu C, Zhu D, Zhai X, Ling C.

Cancer. 2009 Nov 15;115(22):5132-8. doi: 10.1002/cncr.24567.

PMID:
19672999
[PubMed - indexed for MEDLINE]
Free Article
17.

A randomized controlled trial of transcatheter arterial chemoembolization with lipiodol, doxorubicin and cisplatin versus intravenous doxorubicin for patients with unresectable hepatocellular carcinoma.

Mabed M, Esmaeel M, El-Khodary T, Awad M, Amer T.

Eur J Cancer Care (Engl). 2009 Sep;18(5):492-9. doi: 10.1111/j.1365-2354.2008.00984.x.

PMID:
19453695
[PubMed - indexed for MEDLINE]
18.

Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy.

Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, Aino H, Nakano M, Kawaguchi A, Kakuma T, Sata M.

J Gastroenterol. 2012 Jun;47(6):686-95. doi: 10.1007/s00535-012-0555-6. Epub 2012 Mar 1.

PMID:
22382631
[PubMed - indexed for MEDLINE]
19.

Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study.

Biselli M, Andreone P, Gramenzi A, Trevisani F, Cursaro C, Rossi C, Ricca Rosellini S, Cammà C, Lorenzini S, Stefanini GF, Gasbarrini G, Bernardi M.

Clin Gastroenterol Hepatol. 2005 Sep;3(9):918-25.

PMID:
16234031
[PubMed - indexed for MEDLINE]
20.

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk